VP, Clinical Trial Operations
Tue, Oct 24, 2023
Oct 24
5,200 shares @ $19.11
Decreased holdings by -4.70%
11th largest trade (out of 43)
Positive 90D History
Trade made by an officer
Unscheduled trade
100% win rate · +45.2% median edge vs SPY (11 trades, 90-day · small sample)
Price 17% below 200-day moving average
Small Cap stock — insider trades carry more weight